1,042 results on '"Van Bambeke, Françoise"'
Search Results
2. In vitro assessment of the risk of ABCB1-mediated drug–drug interaction between rivaroxaban and tacrolimus in human embryonic kidney 293 recombinant cell lines
3. Repurposing DNase I and alginate lyase to degrade the biofilm matrix of dual-species biofilms of Staphylococcus aureus and Pseudomonas aeruginosa grown in artificial sputum medium: In-vitro assessment of their activity in combination with broad-spectrum antibiotics
4. In memoriam: Pierre Cornelis (1949–2023)
5. The polyamino-isoprenyl potentiator NV716 revives disused antibiotics against Gram-negative bacteria in broth, infected monocytes, or biofilms, by disturbing the barrier effect of their outer membrane
6. The membrane-active polyaminoisoprenyl compound NV716 re-sensitizes Pseudomonas aeruginosa to antibiotics and reduces bacterial virulence
7. Synergy between Ursolic and Oleanolic Acids from Vitellaria paradoxa Leaf Extract and β-Lactams against Methicillin-Resistant Staphylococcus aureus: In Vitro and In Vivo Activity and Underlying Mechanisms
8. Antimicrobial potentials of essential oils extracted from West African aromatic plants on common skin infections
9. Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers
10. Pharmacokinetic/pharmacodynamic considerations for new and current therapeutic drugs for uncomplicated gonorrhoea—challenges and opportunities
11. Pharmacomodulations of the benzoyl-thiosemicarbazide scaffold reveal antimicrobial agents targeting d-alanyl-d-alanine ligase in bacterio
12. Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers
13. Understanding Staphylococcus aureus internalisation and induction of antimicrobial tolerance
14. Exploiting phage-antibiotic synergies to disrupt Pseudomonas aeruginosa PAO1 biofilms in the context of orthopedic infections
15. First detection of a plasmid-encoded New-Delhi metallo-beta-lactamase-1 (NDM-1) producing Acinetobacter baumannii using whole genome sequencing, isolated in a clinical setting in Benin
16. Bacteriophages as potential antibiotic potentiators in cystic fibrosis: A new model to study the combination of antibiotics with a bacteriophage cocktail targeting dual species biofilms of Staphylococcus aureus and Pseudomonas aeruginosa
17. In Vitro Models for the Study of the Intracellular Activity of Antibiotics
18. Dose optimization of β-lactam antibiotics in children: from population pharmacokinetics to individualized therapy
19. 2953. PK/PD Comparison of a New Dosing Scheme for Meropenem Adapted to Outpatient Parenteral Antimicrobial Therapy (OPAT) in Non-Critically-Ill Patients
20. Long-term ICU outbreak of carbapenamase-producing organisms associated with contaminated sink drains
21. 1-(2-Hydroxybenzoyl)-thiosemicarbazides are promising antimicrobial agents targeting d-alanine-d-alanine ligase in bacterio
22. Antimicrobial resistance in hospitalized surgical patients: a silently emerging public health concern in Benin
23. Nafcillin Augmentation of Daptomycin and Cathelicidin LL-37 Killing of Methicillin-resistant Staphylococcus epidermidis: Foundations of Successful Therapy of Endocarditis
24. Intracellular Staphylococcus aureus persisters upon antibiotic exposure
25. Natural and hemi-synthetic pentacyclic triterpenes as antimicrobials and resistance modifying agents against Staphylococcus aureus: a review
26. Linezolid toxicity in clinical practice: towards a better detection of at-risk patients? Interim analysis of a prospective multicentric study
27. Discovery and Characterization of Selective Bacteriocins for the Treatment of Staphylococcus aureus
28. Modulating antibiotic activity towards respiratory bacterial pathogens by co-medications: a multi-target approach
29. Increase of efflux-mediated resistance in Pseudomonas aeruginosa during antibiotic treatment in patients suffering from nosocomial pneumonia
30. Inhibition of the Injectisome and Flagellar Type III Secretion Systems by INP1855 Impairs Pseudomonas aeruginosa Pathogenicity and Inflammasome Activation
31. EDITORIAL COMMENTARY: Colistin and a New Paradigm in Drug Development
32. Macrolides and Ketolides
33. Thrice-weekly temocillin administered after each dialysis session is appropriate for the treatment of serious Gram-negative infections in haemodialysis patients
34. Correction for Ruiz-Sorribas et al., “Hydrolytic Enzymes as Potentiators of Antimicrobials against an Inter-Kingdom Biofilm Model”
35. Editorial for the Special Issue “A Themed Issue in Honor of Professor Hartmut Derendorf—Outstanding Contributions in the Fields of Quantitative Clinical Pharmacology”
36. Development of an innovative in vivo model of PJI treated with DAIR
37. Existing and emerging therapies for the treatment of invasive candidiasis and candidemia
38. Strain-to-strain variability among Staphylococcus aureus causing prosthetic joint infection drives heterogeneity in response to levofloxacin and rifampicin
39. Characterisation of a collection of Streptococcus pneumoniae isolates from patients suffering from acute exacerbations of chronic bronchitis: In vitro susceptibility to antibiotics and biofilm formation in relation to antibiotic efflux and serotypes/serogroups
40. Mechanisms of Action
41. List of Contributors
42. Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review
43. Preliminary evidences of the direct and indirect antimicrobial activity of 12 plants used in traditional medicine in Africa
44. Binding of temocillin to plasma proteins in vitro and in vivo: the importance of plasma protein levels in different populations and of co-medications
45. Population Pharmacokinetics of Temocillin Administered by Continuous Infusion in Patients with Septic Shock Associated with Intra-Abdominal Infection and Ascitic Fluid Effusion
46. Healthcare Professionals’ Knowledge and Beliefs on Antibiotic Prophylaxis in Cesarean Section: A Mixed-Methods Study in Benin
47. 2-Aminobenzothiazole derivatives: Search for new antifungal agents
48. Role of Efflux in Antibiotic Resistance of Achromobacter xylosoxidans and Achromobacter insuavis Isolates From Patients With Cystic Fibrosis
49. Development Of A Novel Prosthetic Joint Infection In-Vivo Model: Focus On DAIR And Vancomycin Pharmacokinetics
50. Reviving disused antibiotics against Gram-negative ESKAPE pathogens : combination with the polyaminoisoprenyl potentiator NV716
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.